ERYTECH PHARMA is about to announce earnings — here's what Wall Street expects

• ERYTECH PHARMA releases figures for the most recent quarter on September 20.
• Wall Street analysts expect ERYTECH PHARMA will be reporting losses per share of €0.490.
• Go here to watch ERYTECH PHARMA stock price in real-time on Markets Insider.

On September 20, ERYTECH PHARMA will report earnings from the Q2.

1 analyst forecasts losses of €0.490 per share compared to losses of €0.970 per share in the same quarter of the previous year.

Wall Street expects ERYTECH PHARMA to report sales of €1.0 million, an decrease of 9.09% over the same period last year.

With regard to the current fiscal year, analysts expect a loss per share of €2.970, while the previous year saw a profit of €3.995.

This story was written by Markets Insider's RoboEddy, which automatically writes these stories based on data provided by our partners.